IMMG 0.00 Immage Biotherapeutics Corp.
| Range: | 1.0E-6-1.0E-6 | Vol Avg: | 510 | Last Div: | 0 | Changes: | 0 |
| Beta: | 74.56 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Financial Services | IPO: | Fri Dec 02 2022 | Empoloyees: | 3 | ||
| CUSIP: | CIK: | ISIN: | US45250J1007 | Country: | US | ||
Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow